These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18936609)

  • 41. Thyroidectomy or radioiodine? The value of ultrasonography and cytology in the assessment of nodular lesions in Graves' hyperthyroidism.
    Wang CY; Chang TJ; Chang TC; Hsiao YL; Chen MH; Huang SH
    Am Surg; 2001 Aug; 67(8):721-6. PubMed ID: 11510570
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.
    Bahn Chair RS; Burch HB; Cooper DS; Garber JR; Greenlee MC; Klein I; Laurberg P; McDougall IR; Montori VM; Rivkees SA; Ross DS; Sosa JA; Stan MN; ;
    Thyroid; 2011 Jun; 21(6):593-646. PubMed ID: 21510801
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Coincidence of unifocal thyroid autonomy and follicular carcinoma. Case report].
    Einert A; Blattmann H; Reinhardt M; Moser E
    Radiologe; 1995 Aug; 35(8):531-4. PubMed ID: 7568800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
    Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
    J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amiodarone-induced thyrotoxicosis. A review.
    Piga M; Serra A; Boi F; Tanda ML; Martino E; Mariotti S
    Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters.
    Huysmans AK; Hermus RM; Edelbroek MA; Tjabbes T; Oostdijk ; Ross HA; Corstens FH; Kloppenborg PW
    Thyroid; 1997 Aug; 7(4):535-9. PubMed ID: 9292939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [NEW DATA ON THE CLINICAL DIAGNOSIS AND THERAPY OF HYPERFUNCTIONING THYROID ADENOMA].
    HOLAN T; DUMITRESCU G; FARCASANU M; GHERMAN C; SZASZ A
    Med Interna (Bucur); 1964 Feb; 16():153-61. PubMed ID: 14142013
    [No Abstract]   [Full Text] [Related]  

  • 48. [Results of selective goiter resection in functional autonomy].
    Reichmann I; Hörmann R; Zander C; Friedrich J; Krause U
    Zentralbl Chir; 1998; 123(1):34-8. PubMed ID: 9542027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hürthle cell lesions of the thyroid gland.
    Thompson NW; Dunn EL; Batsakis JG; Nishiyama RH
    Surg Gynecol Obstet; 1974 Oct; 139(4):555-60. PubMed ID: 4479589
    [No Abstract]   [Full Text] [Related]  

  • 50. Correlation of clinicopathological features and expression of molecular markers with prognosis after ¹³¹I treatment of differentiated thyroid carcinoma.
    Qin C; Cau W; Zhang Y; Mghanga FP; Lan X; Gao Z; An R
    Clin Nucl Med; 2012 Mar; 37(3):e40-6. PubMed ID: 22310269
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum interleukin-6 in amiodarone-induced thyrotoxicosis.
    Bartalena L; Grasso L; Brogioni S; Aghini-Lombardi F; Braverman LE; Martino E
    J Clin Endocrinol Metab; 1994 Feb; 78(2):423-7. PubMed ID: 8106631
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thyrotoxicosis--surgical management in the era of evidence-based medicine: experience in western India with 752 cases.
    Bhansali SK; Chandalia HB
    Asian J Surg; 2002 Oct; 25(4):291-9. PubMed ID: 12471001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The risk factors for malignancy in surgically treated patients for Graves' disease, toxic multinodular goiter, and toxic adenoma.
    Senyurek Giles Y; Tunca F; Boztepe H; Kapran Y; Terzioglu T; Tezelman S
    Surgery; 2008 Dec; 144(6):1028-36; discussion 1036-7. PubMed ID: 19041014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toxic multinodular goiter: a variant of autoimmune hyperthyroidism.
    Kraiem Z; Glaser B; Yigla M; Pauker J; Sadeh O; Sheinfeld M
    J Clin Endocrinol Metab; 1987 Oct; 65(4):659-64. PubMed ID: 2888784
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relevance of cause of hyperthyroidism in determining its management.
    Veneman TF; Weymer M; Tjabbes T; van Haeften TW
    Neth J Med; 1989 Dec; 35(5-6):303-8. PubMed ID: 2635287
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A round table discussion. Goiter: the therapeutic choices.
    Schultz AL; Beahrs OH; McConahey WM; Nuttall FQ; Wong ET
    Geriatrics; 1973 Jul; 28(7):80-96. PubMed ID: 4122973
    [No Abstract]   [Full Text] [Related]  

  • 57. [Thyroid hemiagenesis (single thyroid lobe). 8 cases (author's transl)].
    Letonturier P; Hazard J; Tourneur R; Perlemuter L; Angel R
    Nouv Presse Med; 1979 Mar; 8(15):1227-9. PubMed ID: 440944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recurrent disease in juvenile differentiated thyroid carcinoma: prognostic factors, treatments, and outcomes.
    Mihailovic J; Nikoletic K; Srbovan D
    J Nucl Med; 2014 May; 55(5):710-7. PubMed ID: 24722527
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radioiodine in diagnosis and therapy of hyperthyroidism. Hyperthyroidism caused by hyperfunctioning thyroid adenoma.
    SKILLERN PG; McCULLAGH EP; CLAMEN M
    Arch Intern Med; 1962 Dec; 110():888-97. PubMed ID: 13977899
    [No Abstract]   [Full Text] [Related]  

  • 60. The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives.
    Laurberg P; Jørgensen T; Perrild H; Ovesen L; Knudsen N; Pedersen IB; Rasmussen LB; Carlé A; Vejbjerg P
    Eur J Endocrinol; 2006 Aug; 155(2):219-28. PubMed ID: 16868134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.